A Stanford physician co-authored a list of likely biological factors underlying the reduced development of COVID-19 for children compared to adults.
Stanford-led research finds that the blood-brain barrier may be much more permeable -- albeit selectively so -- than previously thought.
People taking two common types of drugs for hypertension are at no heightened risk, as has been feared, for increased severity or complications of COVID-19.
Two recent Stanford-led studies show the value of tweaking vaccines to enlist the entire immune system — not just part of it — in preventing HIV infection.
How exactly does the antiviral drug remdesivir counter SARS-CoV-2 – the coronavirus strain responsible for COVID-19? And how well?
The COVID-19 pandemic gives new relevance to a synthetic substance developed by Stanford researchers that could help respiratory patients breathe easier.
In U.S. hospitals, the frequency of brain imaging for acute stroke patients dipped, suggesting hesitancy to seek medical care for non-COVID-19 conditions.
Even if chloroquine and hydroxychloroquine don't end up being the best treatment for COVID-19, observing how they work in a dish can teach scientists a lot.
An innovative stem cell delivery method vastly improves the viability of tissue regenerating cells in animal spinal-cord injury models.
A look at how viruses — including coronavirus — enter cells, use their molecular machinery to copy themselves and escape. And how to stop them.
Amid the COVID-19 pandemic, viruses are getting a lot of attention; here's an inside look into the most abundant life form on Earth.
In a clinical trial, a tiny prosthetic retinal device invented by a Stanford researcher has proved its potential ability to restore eyesight to the blind.
A study links ulcerative colitis to the depletion of important acids ordinarily produced by a set of gut microbes mysteriously missing in action.
Cellular respiration has a downside: Its byproducts harm the mitochondria that perform this trick, endangering our brain cells.
A new study has identified T cells targeting the Epstein-Barr virus in autopsied Alzheimer's brains and in cerebrospinal fluid of Alzheimer's patients.
Stanford researchers have teased apart the addictive and pro-social effects of MDMA -- suggesting the possibliity of a non-addictive therapy.